Los adolescentes y adultos con asma grave sin control que recibieron tezepelumab, un anticuerpo contra la citocina TSL (thymic stromal lymphopoietin), tuvieron menos crisis y mejoraron la función pulmonar, de acuerdo con un ensayo clínico reportado en Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, et al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Eng J Med. 2021;
– SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis
– Diagnostic performance of anti-Zika virus IgM, IgAM and IgG ELISAs during co-circulation of Zika, dengue, and chikungunya viruses in Brazil and Venezuela
– Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2
– Effect of Age on the Immune and Visceral Organ Weights and Cecal Traits in Modern Broilers
– Differential Induction Pattern Towards Classically Activated Macrophages in Response to an Immunomodulatory Extract from Pleurotus ostreatus Mycelium
En la sección: Artículos de revisión, Autores cubanos en revistas extranjeras, COVID-19, Infectología, Inflamación, Inmunidad de mucosas, Inmunidad innata, Inmunología veterinaria, Inmunoterapia. Publicado en: . 
– Immunodominant antibody germlines in COVID-19. J Exp Med 2021;218(5):e20210281.
– High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China. Front. Immunol., 2021; https://doi.org/10.3389/fimmu.2021.627844.
– Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell 2021;184(5):1201-1213.e14.
– IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study. J Immunol April 1, 2021;206(7):1569-1575.
– Lasting memories of SARS-CoV-2 infection. J Exp Med 2021;218(4):e20210210.
– What scientists do and don’t know about the Oxford–AstraZeneca COVID vaccine. Nature 2021; doi: https://doi.org/10.1038/d41586-021-00785-7.
– Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 2021;371(6529):eabf4063.
En la sección: COVID-19, Infectología, Inmunoterapia, Vacunología. Publicado en: .
Estudios del Rilzabrutinib, un inhibidor de la enzima tirosina-cinasa de Bruton que se administra por vía oral, en animales de laboratorio han mostrado su potencial en varios cuadros inmunopatológicos, como artritis, nefritis, trombocitopenia y pénfigo. Así se describe en Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease. J Immunol April 1, 2021;206(7):1454-1468.
En la sección: Autoinmunidad, Inmunoterapia. Publicado en: .
– A Critical Review about Different Vaccines against Classical Swine Fever Virus and Their Repercussions in Endemic Regions. Vaccines (Basel). 2021 Feb 15;9(2):154.
– Porvac® Subunit Vaccine E2-CD154 Induces Remarkable Rapid Protection against Classical Swine Fever Virus. Vaccines (Basel). 2021 Feb 17;9(2):167.
– Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety. BMC Cancer 2021;21:270.
En la sección: Autores cubanos en revistas extranjeras, Infectología, Inmunoterapia, Vacunología. Publicado en: .
– Can Anti-Ribosomal Antibodies Improve Systemic Lupus Erythematosus Diagnosis?
– An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases
– The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1
– Immunogenicity of E2CD154 Subunit Vaccine Candidate against Classical Swine Fever in Piglets with Different Levels of Maternally Derived Antibodies
En la sección: Autoinmunidad, Autores cubanos en revistas extranjeras, COVID-19, Infectología, Inflamación, Inmunidad tumoral, Inmunología veterinaria, Inmunoterapia, Vacunología. Publicado en: .
